Federal Register / Vol. 89, No. 214 / Tuesday, November 5, 2024 / Notices 87883 

designated, the name of the service area, 

population group, or facility involved is 

listed under the county name. A county 

that has a whole county geographic or 

population group HPSA is indicated by 

the phrase ‘‘County’’ following the 

county name. 

Development of the Designation and 

Withdrawal Lists 

HRSA continuously receives requests 

for designation or withdrawal of a 

particular geographic area, population 

group, or facility as a HPSA. Under a 

Cooperative Agreement between HRSA 

and the 54 state and territorial primary 

care offices (PCOs), PCOs conduct needs 

assessments and submit applications to 

HRSA to designate HPSAs. HRSA refers 

requests that come from other sources to 

PCOs for review. In addition, interested 

parties, including governors, state 

primary care associations, and state 

professional associations, are notified of 

requests so that they may submit their 

comments and recommendations. 

HRSA reviews each recommendation 

for possible addition, continuation, 

revision, or withdrawal. Following 

review, HRSA notifies the appropriate 

agency, individuals, and interested 

organizations of each designation of a 

HPSA, rejection of recommendation for 

HPSA designation, revision of a HPSA 

designation, and/or advance notice of 

pending withdrawals from the HPSA 

list. Designations (or revisions of 

designations) are effective as of the date 

on the notification from HRSA and are 

updated daily on the HRSA Data 

Warehouse website. The effective date 

of a withdrawal will be the next 

publication of a notice regarding the list 

of designated HPSAs in the Federal 

Register. 

Diana Espinosa, 

Principal Deputy Administrator. 

[FR Doc. 2024–25624 Filed 11–4–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Secretary; Notice of 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Interagency Pain 

Research Coordinating Committee. 

The meeting will be held as a virtual 

meeting and will be open to the public 

as indicated below. Individuals who 

plan to view the virtual meeting and 

need special assistance or other 

reasonable accommodations to view the 

meeting, should notify the Contact 

Person listed below in advance of the 

meeting. The meeting can be accessed 

from the NIH Videocast at the following 

link: https://videocast.nih.gov/. 

Name of Committee: Interagency Pain 

Research Coordinating Committee. 

Date: December 4, 2024. 

Time: 10:15 a.m. to 4:00 p.m. Eastern Time 

(ET). 

Agenda: Interagency Pain Research 

Coordinating Committee member updates 

and other committee business, including 

Federal Pain Research Strategy research 

progress, communication and dissemination 

strategies, and workgroup updates. 

Webcast Live: http://videocast.nih.gov/. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Bethesda, MD 

20892 (Virtual Meeting). 

Contact Person: Leah Pogorzala, Ph.D., 

Policy Analyst, Office of Pain Policy and 

Planning, Office of the Director, National 

Institute of Neurological Disorders and 

Stroke, NIH, Bethesda, MD 20892, Phone: 

(301) 496–4228, Email: leah.pogorzala@

nih.gov. 

Any interested person may file 

written comments with the committee 

by forwarding the statement to the 

Contact Person listed on this notice. The 

statement should include the name, 

address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Written comments should be submitted 

to the contact person by 5:00 p.m. ET on 

November 27, 2024. 

Information is also available on the 

IPRCC website http://iprcc.nih.gov, 

where an agenda and any additional 

information for the meeting will be 

posted when available. 

Dated: October 30, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–25650 Filed 11–4–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following Meetings. 

The Meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Developmental Biology. 

Date: December 2, 2024. 

Time: 12:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Anne Marie Strohecker, 

Ph.D., Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Bethesda, MD 20892, (301) 867–5309, 

stroheckeram@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Health Services and Systems B. 

Date: December 3–4, 2024. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Tara Roshell Earl, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1007C, 

Bethesda, MD 20892, (301) 402–6857, earltr@

mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Microbial Diagnostics, Detection 

and Decontamination. 

Date: December 3–4, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Shinako Takada, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, 301–827–5997, shinako.takada@

nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Special topics in Mechanistic and 

Clinical Neuroscience. 

Date: December 3, 2024. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Address: National Institutes of Health 6701 

Rockledge Drive, Bethesda, MD 20892. 

Meeting Format: Virtual Meeting. 

Contact Person: Suzan Nadi, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5217B, 

MSC 7846, Bethesda, MD 20892, (301) 435– 

1259, nadis@csr.nih.gov. 


ddrumheller on DSK120RN23PROD with NOTICES1